Anthony Chalmers
@profajchalmers.bsky.social
Clinician scientist, radiation oncologist, neuro-oncologist
Gardens, cocktails, Scotland
Gardens, cocktails, Scotland
Reposted by Anthony Chalmers
Want the opportunity to work at the forefront of RT #clinicaltrials? We are hiring!
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Current vacancies – East and North Hertfordshire NHS Trust
Are you a retired NHS employee? You could join the NHS Retirement Fellowship.
www.enherts-tr.nhs.uk
July 23, 2025 at 10:51 AM
Want the opportunity to work at the forefront of RT #clinicaltrials? We are hiring!
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Reposted by Anthony Chalmers
🧠 Why does glioblastoma always outsmart treatment? In our #Neuro-Oncology paper, we identified proneural-mesenchymal hybrid glioblastoma cells that are resistant to therapy and dependent on nuclear import. doi.org/10.1093/neuo...
Short walkthrough below. Let’s dive in! 🧵 (1/9)
#GBM, #BrainTumor
Short walkthrough below. Let’s dive in! 🧵 (1/9)
#GBM, #BrainTumor
July 17, 2025 at 9:08 AM
🧠 Why does glioblastoma always outsmart treatment? In our #Neuro-Oncology paper, we identified proneural-mesenchymal hybrid glioblastoma cells that are resistant to therapy and dependent on nuclear import. doi.org/10.1093/neuo...
Short walkthrough below. Let’s dive in! 🧵 (1/9)
#GBM, #BrainTumor
Short walkthrough below. Let’s dive in! 🧵 (1/9)
#GBM, #BrainTumor
Reposted by Anthony Chalmers
🎗️Today is #GlioblastomaAwarenessDay2025, designed to raise awareness of #glioblastoma, the most common primary brain cancer. At #EANO, we are dedicated to advancing scientific research, improving diagnostic tools, & developing therapies to combat this challenging disease. #GBMDay
👉 @braintumor.org
👉 @braintumor.org
July 16, 2025 at 7:28 AM
🎗️Today is #GlioblastomaAwarenessDay2025, designed to raise awareness of #glioblastoma, the most common primary brain cancer. At #EANO, we are dedicated to advancing scientific research, improving diagnostic tools, & developing therapies to combat this challenging disease. #GBMDay
👉 @braintumor.org
👉 @braintumor.org
Reposted by Anthony Chalmers
Are you looking to start your #lab in a fantastic scientific 🧪environment, with great colleagues, and in a spectacular place to live?
Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland:
www.unil.ch/dof/en/home/...
⏰ Deadline 27 June
Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland:
www.unil.ch/dof/en/home/...
⏰ Deadline 27 June
June 23, 2025 at 5:14 PM
Are you looking to start your #lab in a fantastic scientific 🧪environment, with great colleagues, and in a spectacular place to live?
Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland:
www.unil.ch/dof/en/home/...
⏰ Deadline 27 June
Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland:
www.unil.ch/dof/en/home/...
⏰ Deadline 27 June
Reposted by Anthony Chalmers
Reminder that #ctrad are holding a proposals guidance meeting on 11th July 2025.
We have a limited list of contacts to invite but if you are interested in UK radiation research we would love you to join us.
Please contact ctrad@macmillan.org.uk for details, register and submit a trial idea.
We have a limited list of contacts to invite but if you are interested in UK radiation research we would love you to join us.
Please contact ctrad@macmillan.org.uk for details, register and submit a trial idea.
News for UK radiotherapy community.
Pleased to say that thanks to @macmillancancer we have been able to establish #ctrad.
We plan a proposals guidance meeting on 8.7.25
If you have a new trial idea and wish to attend please contact ctrad@macmillan.org to register
Pleased to say that thanks to @macmillancancer we have been able to establish #ctrad.
We plan a proposals guidance meeting on 8.7.25
If you have a new trial idea and wish to attend please contact ctrad@macmillan.org to register
June 20, 2025 at 3:04 PM
Reminder that #ctrad are holding a proposals guidance meeting on 11th July 2025.
We have a limited list of contacts to invite but if you are interested in UK radiation research we would love you to join us.
Please contact ctrad@macmillan.org.uk for details, register and submit a trial idea.
We have a limited list of contacts to invite but if you are interested in UK radiation research we would love you to join us.
Please contact ctrad@macmillan.org.uk for details, register and submit a trial idea.
Reposted by Anthony Chalmers
Read the latest perspective piece by @sueyom.bsky.social & Mary Helen Barcellos-Hoff in @natrevcancer.nature.com @ucsanfrancisco.bsky.social @ucsfhealth.bsky.social @ucsfcancer.bsky.social
🚨 PERSEPCTIVE 🚨
TGFβ has a well-established role in cancer, yet its blockade has 🔁ly failed in trials. Barcellos-Hoff & Yom use HPV-driven cancers as a model to explain these discrepancies & emphasize the need for refined strategies to enhance therapeutic efficacy.
TGFβ has a well-established role in cancer, yet its blockade has 🔁ly failed in trials. Barcellos-Hoff & Yom use HPV-driven cancers as a model to explain these discrepancies & emphasize the need for refined strategies to enhance therapeutic efficacy.
Revisiting the TGFβ paradox: insights from HPV-driven cancer and the DNA damage response - Nature Reviews Cancer
Transforming growth factor-β (TGFβ) has a well-established role in malignancy and its inhibition has demonstrated strong preclinical activity. However, TGFβ blockade has repeatedly failed in clinical trials. Here, Barcellos-Hoff and Yom utilize human papillomavirus (HPV)-driven cancer as a model to explain these discrepancies and emphasize the need for refined strategies and understanding of TGFβ signalling to enhance therapeutic efficacy.
bit.ly
May 27, 2025 at 6:40 PM
Read the latest perspective piece by @sueyom.bsky.social & Mary Helen Barcellos-Hoff in @natrevcancer.nature.com @ucsanfrancisco.bsky.social @ucsfhealth.bsky.social @ucsfcancer.bsky.social
Thank you Robert and MacMillan for reviving #CTRad - the most effective and impactful academic organisation I’ve ever been a part of. The future of #radiotherapy research in the UK is in safe hands.
News for UK radiotherapy community.
Pleased to say that thanks to @macmillancancer we have been able to establish #ctrad.
We plan a proposals guidance meeting on 8.7.25
If you have a new trial idea and wish to attend please contact ctrad@macmillan.org to register
Pleased to say that thanks to @macmillancancer we have been able to establish #ctrad.
We plan a proposals guidance meeting on 8.7.25
If you have a new trial idea and wish to attend please contact ctrad@macmillan.org to register
June 1, 2025 at 11:07 AM
Thank you Robert and MacMillan for reviving #CTRad - the most effective and impactful academic organisation I’ve ever been a part of. The future of #radiotherapy research in the UK is in safe hands.
Reposted by Anthony Chalmers
We are pleased to annouce that a 3.5-year PhD position is available in the GDSC, for a project jointly supervised by Prof. Hochegger and Dr. Oliver. For additional details, inc. candidate eligibility, and how to apply:
www.sussex.ac.uk/study/fees-f...
www.sussex.ac.uk/study/fees-f...
Life Sciences PhD Genome Stability - Understanding and Targeting Cell Cycle Control in Cancer : University of Sussex
www.sussex.ac.uk
May 23, 2025 at 8:21 AM
We are pleased to annouce that a 3.5-year PhD position is available in the GDSC, for a project jointly supervised by Prof. Hochegger and Dr. Oliver. For additional details, inc. candidate eligibility, and how to apply:
www.sussex.ac.uk/study/fees-f...
www.sussex.ac.uk/study/fees-f...
Reposted by Anthony Chalmers
📢 Reminder: Apply now to join the #EANO Nurse & Allied Healthcare Professional Committee (NAC)! Help shape EANO’s future & represent your field in the #NeuroOncology community.
🗓️ Deadline: May 31
🔗 bit.ly/45kRJyP
We look forward to meeting you!
@drflorienboele.bsky.social @karinpiil.bsky.social
🗓️ Deadline: May 31
🔗 bit.ly/45kRJyP
We look forward to meeting you!
@drflorienboele.bsky.social @karinpiil.bsky.social
May 22, 2025 at 2:09 PM
📢 Reminder: Apply now to join the #EANO Nurse & Allied Healthcare Professional Committee (NAC)! Help shape EANO’s future & represent your field in the #NeuroOncology community.
🗓️ Deadline: May 31
🔗 bit.ly/45kRJyP
We look forward to meeting you!
@drflorienboele.bsky.social @karinpiil.bsky.social
🗓️ Deadline: May 31
🔗 bit.ly/45kRJyP
We look forward to meeting you!
@drflorienboele.bsky.social @karinpiil.bsky.social
Reposted by Anthony Chalmers
Tony Oliver’s and my lab have a joint phd position available to investigate mitotic entry control mechanisms
Please forward to prospective students! Thank you
url.uk.m.mimecastprotect.com/s/ukMTCoy6DT...
Please forward to prospective students! Thank you
url.uk.m.mimecastprotect.com/s/ukMTCoy6DT...
PhD Studentship: Understanding and Targeting Cell Cycle Control in Cancer at University of Sussex
At jobs.ac.uk, you can apply for a PhD Studentship: Understanding and Targeting Cell Cycle Control in Cancer. Explore our diverse range of PhD opportunities today.
url.uk.m.mimecastprotect.com
May 21, 2025 at 10:22 AM
Tony Oliver’s and my lab have a joint phd position available to investigate mitotic entry control mechanisms
Please forward to prospective students! Thank you
url.uk.m.mimecastprotect.com/s/ukMTCoy6DT...
Please forward to prospective students! Thank you
url.uk.m.mimecastprotect.com/s/ukMTCoy6DT...
Reposted by Anthony Chalmers
“Starmer's EU deal is a big break in the suffocating Brexit consensus that has held Britain back for a decade. For the first time a UK government is doing things to actually undo the damage of Brexit, rather than increase it. For that alone it should be welcomed” 👏
bylinetimes.com/2025/05/19/k...
bylinetimes.com/2025/05/19/k...
Keir Starmer's EU Reset Deal Is the First Crack in the Brexit Wall Holding Britain Back
This agreement marks the beginning of the end of the suffocating Brexit consensus that has gripped British politics for a decade, argues Adam Bienkov
bylinetimes.com
May 19, 2025 at 2:26 PM
“Starmer's EU deal is a big break in the suffocating Brexit consensus that has held Britain back for a decade. For the first time a UK government is doing things to actually undo the damage of Brexit, rather than increase it. For that alone it should be welcomed” 👏
bylinetimes.com/2025/05/19/k...
bylinetimes.com/2025/05/19/k...
Reposted by Anthony Chalmers
🧠New Neurology Fellowship Opportunity in London!
Join a cutting-edge Fellowship programme, designed to deepen your clinical expertise in the evolving field of neuro-oncology.
🔗Find out more here: www.tessajowellbraincancermission.org/news/tessa-j...
@nihr.bsky.social @kingshealth.bsky.social
Join a cutting-edge Fellowship programme, designed to deepen your clinical expertise in the evolving field of neuro-oncology.
🔗Find out more here: www.tessajowellbraincancermission.org/news/tessa-j...
@nihr.bsky.social @kingshealth.bsky.social
May 14, 2025 at 9:34 AM
🧠New Neurology Fellowship Opportunity in London!
Join a cutting-edge Fellowship programme, designed to deepen your clinical expertise in the evolving field of neuro-oncology.
🔗Find out more here: www.tessajowellbraincancermission.org/news/tessa-j...
@nihr.bsky.social @kingshealth.bsky.social
Join a cutting-edge Fellowship programme, designed to deepen your clinical expertise in the evolving field of neuro-oncology.
🔗Find out more here: www.tessajowellbraincancermission.org/news/tessa-j...
@nihr.bsky.social @kingshealth.bsky.social
Reposted by Anthony Chalmers
Five studies presented by experts including @montefiored.bsky.social from 🇬🇧 @universityofleeds.bsky.social / @leedsth.nhs.uk, 🇳🇱 @nkinl.bsky.social, and 🏴 @uofgcancersciences.bsky.social at #ESTRO25 showcase how #radiotherapy is reshaping treatments for anal and rectal #cancer.
Five major advances in anal and rectal cancer treatment with radiotherapy
Rectal cancer is a type of bowel cancer that develops in the last several centimetres of the large intestine, just before the anus. It’s one of the most common cancers in Europe, with over 125,000 peo...
healthcare-in-europe.com
May 12, 2025 at 6:33 AM
Five studies presented by experts including @montefiored.bsky.social from 🇬🇧 @universityofleeds.bsky.social / @leedsth.nhs.uk, 🇳🇱 @nkinl.bsky.social, and 🏴 @uofgcancersciences.bsky.social at #ESTRO25 showcase how #radiotherapy is reshaping treatments for anal and rectal #cancer.
Reposted by Anthony Chalmers
Or to put it another way, overseas students now subsidise the cost of teaching each UK undergraduate by an average of £2,500 each. Take them away and you've got an absolutely existential crisis for universities.
www.prospectmagazine.co.uk/politics/pol...
www.prospectmagazine.co.uk/politics/pol...
May 5, 2025 at 10:45 AM
Or to put it another way, overseas students now subsidise the cost of teaching each UK undergraduate by an average of £2,500 each. Take them away and you've got an absolutely existential crisis for universities.
www.prospectmagazine.co.uk/politics/pol...
www.prospectmagazine.co.uk/politics/pol...
Reposted by Anthony Chalmers
🔈 I am honored to be running alongside
Sunil Krishnan & David Yu
for Vice-President Elect of RRS
🙏🙏🙏
🧐You can find more info on the candidates here 👉
ftp.ameetingbydesign.com/ambddrop/202...
Vote by May 1️⃣3️⃣ radres.org/Login.aspx
@cvanpouillebox.bsky.social
@profajchalmers.bsky.social
Sunil Krishnan & David Yu
for Vice-President Elect of RRS
🙏🙏🙏
🧐You can find more info on the candidates here 👉
ftp.ameetingbydesign.com/ambddrop/202...
Vote by May 1️⃣3️⃣ radres.org/Login.aspx
@cvanpouillebox.bsky.social
@profajchalmers.bsky.social
May 3, 2025 at 6:17 PM
🔈 I am honored to be running alongside
Sunil Krishnan & David Yu
for Vice-President Elect of RRS
🙏🙏🙏
🧐You can find more info on the candidates here 👉
ftp.ameetingbydesign.com/ambddrop/202...
Vote by May 1️⃣3️⃣ radres.org/Login.aspx
@cvanpouillebox.bsky.social
@profajchalmers.bsky.social
Sunil Krishnan & David Yu
for Vice-President Elect of RRS
🙏🙏🙏
🧐You can find more info on the candidates here 👉
ftp.ameetingbydesign.com/ambddrop/202...
Vote by May 1️⃣3️⃣ radres.org/Login.aspx
@cvanpouillebox.bsky.social
@profajchalmers.bsky.social
Reposted by Anthony Chalmers
!!*RECRUITING*!!
We are looking for an enthusiastic PhD student @cruk-si.bsky.social @uofglasgow.bsky.social! This exciting fully funded project aims to unravel metabolic determinants of cachexia. Fancy some great teamwork with the labs of Owen Sansom and Campbell Roxburgh? Apply below!👇
We are looking for an enthusiastic PhD student @cruk-si.bsky.social @uofglasgow.bsky.social! This exciting fully funded project aims to unravel metabolic determinants of cachexia. Fancy some great teamwork with the labs of Owen Sansom and Campbell Roxburgh? Apply below!👇
May 3, 2025 at 3:50 PM
!!*RECRUITING*!!
We are looking for an enthusiastic PhD student @cruk-si.bsky.social @uofglasgow.bsky.social! This exciting fully funded project aims to unravel metabolic determinants of cachexia. Fancy some great teamwork with the labs of Owen Sansom and Campbell Roxburgh? Apply below!👇
We are looking for an enthusiastic PhD student @cruk-si.bsky.social @uofglasgow.bsky.social! This exciting fully funded project aims to unravel metabolic determinants of cachexia. Fancy some great teamwork with the labs of Owen Sansom and Campbell Roxburgh? Apply below!👇
Reposted by Anthony Chalmers
HYPO-RT-PC 10 year data presented at #ESTRO2025. Seven fractions def non-inferior to 39 fractions, suggestion that 7 fractions might even be more likely to cure?
May 3, 2025 at 1:34 PM
HYPO-RT-PC 10 year data presented at #ESTRO2025. Seven fractions def non-inferior to 39 fractions, suggestion that 7 fractions might even be more likely to cure?
Reposted by Anthony Chalmers
Job alert: Clinical Lead wanted for the new UK Collaborative for Cancer Clinical Research (UKCCCR) – part of the Govt’s Cancer Healthcare Goals Programme.
💼 1 day/week (consultancy) | Hosted by
@amrc-uk.bsky.social proudly supported by us.
Apply here 👉
💼 1 day/week (consultancy) | Hosted by
@amrc-uk.bsky.social proudly supported by us.
Apply here 👉
Clinical Lead, UK Collaborative for Cancer Clinical Research (UKCCCR)
Salary: up to £21,000 for 0.2FTE Location: Hybrid working (home and office in central London, WC1) Deadline: 8am, Monday 12th May 2025 Duration: one year fixed term (initially, with the expectation that the role will be renewed) Secondments welcome About the role AMRC has agreed to host the secretariat for a new UK Collaborative for Cancer Clinical Research (UKCCCR), which will be part of the Government’s Cancer Healthcare Goals Programme. A number of Cancer Clinical Research Groups (CRGs), each focusing on a specific cancer type or cross-cutting theme, bring together the cancer research community, to encourage strategic discussion and identify new areas of research. Many of the Secretariats for the CRGs are now run by AMRC member charities. The UKCCCR will provide a light touch secretariat to improve central coordination of these groups, allowing them to identify shared priorities, reduce duplication and be as effective as possible. The Clinical Lead will provide clinical expertise, advice and leadership on a consultancy basis to support UKCCCR and the programme manager. The role will require up to one day a week time commitment on a flexible basis. Please see the job description and person specification for full details. How to apply Please read the job description and person specification. Please send your CV and a cover letter explaining what makes you a strong candidate for this role to jobs@amrc.org.uk. Please quote ‘UKCCCR Clinical Lead’ in the email subject. If you have any questions about the role, or wish to have an informal conversation, please email jobs@amrc.org.uk.
www.amrc.org.uk
May 1, 2025 at 5:03 PM
Job alert: Clinical Lead wanted for the new UK Collaborative for Cancer Clinical Research (UKCCCR) – part of the Govt’s Cancer Healthcare Goals Programme.
💼 1 day/week (consultancy) | Hosted by
@amrc-uk.bsky.social proudly supported by us.
Apply here 👉
💼 1 day/week (consultancy) | Hosted by
@amrc-uk.bsky.social proudly supported by us.
Apply here 👉
Reposted by Anthony Chalmers
Runcorn worn by 6 votes on a turnout of only 46.2% tells me two things:
Your vote is always important
Too many people think it isn’t
Your vote is always important
Too many people think it isn’t
May 2, 2025 at 6:07 AM
Runcorn worn by 6 votes on a turnout of only 46.2% tells me two things:
Your vote is always important
Too many people think it isn’t
Your vote is always important
Too many people think it isn’t
Reposted by Anthony Chalmers
Anthony Chalmers presents studies on combining radiation therapy and DNA damage response inhibitors, potential mechanisms and clinical implications.
#AACR25 | @profajchalmers.bsky.social
#AACR25 | @profajchalmers.bsky.social
April 27, 2025 at 3:33 PM
Anthony Chalmers presents studies on combining radiation therapy and DNA damage response inhibitors, potential mechanisms and clinical implications.
#AACR25 | @profajchalmers.bsky.social
#AACR25 | @profajchalmers.bsky.social
Reposted by Anthony Chalmers
New episode of Simply Oncology coming for Head and Neck patients.
🎙️We speak to the superb @clairepaterson.bsky.social about radiotherapy and new treatments in H&N cancers.
🎙️A great resource for any patient undergoing H&N treatment
@simplyoncology.bsky.social
🎙️We speak to the superb @clairepaterson.bsky.social about radiotherapy and new treatments in H&N cancers.
🎙️A great resource for any patient undergoing H&N treatment
@simplyoncology.bsky.social
April 24, 2025 at 7:04 PM
New episode of Simply Oncology coming for Head and Neck patients.
🎙️We speak to the superb @clairepaterson.bsky.social about radiotherapy and new treatments in H&N cancers.
🎙️A great resource for any patient undergoing H&N treatment
@simplyoncology.bsky.social
🎙️We speak to the superb @clairepaterson.bsky.social about radiotherapy and new treatments in H&N cancers.
🎙️A great resource for any patient undergoing H&N treatment
@simplyoncology.bsky.social
Congratulations to the authors for completing this randomised study in an extremely rare cancer. Clear evidence of overall survival benefit from the addition of chemoradiation to standard of care. #radonc
RACE-GB, the first ever phase 3 randomized study showing overall survival improvement from chemotherapy combined with #radiation for gallbladder cancer.
Article: www.redjournal.org/article/S036...
Podcast: www.redjournal.org/audio-do/red...
Article: www.redjournal.org/article/S036...
Podcast: www.redjournal.org/audio-do/red...
A Randomized Study of Consolidation Chemoradiotherapy Versus Observation After First-line Chemotherapy in Advanced Gallbladder Cancers: RACE-GB study
Chemotherapy (CT) is the standard of care for patients presenting with unresectable
advanced gallbladder carcinoma (GBC) but their prognosis remains poor. The value of
consolidation CT and radiation t...
www.redjournal.org
April 14, 2025 at 10:32 PM
Congratulations to the authors for completing this randomised study in an extremely rare cancer. Clear evidence of overall survival benefit from the addition of chemoradiation to standard of care. #radonc
How brilliant is this?! Well done Cassie for continually pushing the boundaries of what scientists can do.
Recently, I've had the unique opportunity to visit prisons & teach incarcerated learners about cancer metabolism. This programme, Cell to Cell @celltocellscot.bsky.social, allows us to attend the Education Department of prisons within Scotland to...(1/4)
April 5, 2025 at 9:54 AM
How brilliant is this?! Well done Cassie for continually pushing the boundaries of what scientists can do.
Reposted by Anthony Chalmers
📢 Call for Applications
EANO & @neuroonc.bsky.social are seeking a new Editor-in-Chief for Neuro-Oncology Advances!
✅ Strong background in #NeuroOncology
✅ Editorial leadership experience
🗓️ Deadline: May 31, 2025
🔗 More info: bit.ly/4j9AqV7
#EANO #SNO #NeuroOncologyAdvances #CallForApplications
EANO & @neuroonc.bsky.social are seeking a new Editor-in-Chief for Neuro-Oncology Advances!
✅ Strong background in #NeuroOncology
✅ Editorial leadership experience
🗓️ Deadline: May 31, 2025
🔗 More info: bit.ly/4j9AqV7
#EANO #SNO #NeuroOncologyAdvances #CallForApplications
April 3, 2025 at 8:05 AM
📢 Call for Applications
EANO & @neuroonc.bsky.social are seeking a new Editor-in-Chief for Neuro-Oncology Advances!
✅ Strong background in #NeuroOncology
✅ Editorial leadership experience
🗓️ Deadline: May 31, 2025
🔗 More info: bit.ly/4j9AqV7
#EANO #SNO #NeuroOncologyAdvances #CallForApplications
EANO & @neuroonc.bsky.social are seeking a new Editor-in-Chief for Neuro-Oncology Advances!
✅ Strong background in #NeuroOncology
✅ Editorial leadership experience
🗓️ Deadline: May 31, 2025
🔗 More info: bit.ly/4j9AqV7
#EANO #SNO #NeuroOncologyAdvances #CallForApplications